CD19 and acute lymphoblastic leukemia: Moreover, an in vitro screen of CD19+ acute lymphoblastic leukemia cells co-cultured with CD19-targeted CAR T cells has found that deficiency in the death receptor apoptotic signaling pathway mediates cancer cell resistance and induces CAR T cell dysfunction (104).